RecruitingNCT07422987
GLP-1RA Effects on Lean Mass and Bone Health in Midlife Women
Sponsor
University of Kansas Medical Center
Enrollment
50 participants
Start Date
Feb 12, 2026
Study Type
OBSERVATIONAL
Conditions
Summary
This study is designed with the interest to learn on the effects of estrogen levels and how it affects body compositions and muscle function in midlife women who are taking a GLP-1RA for weight loss.
Eligibility
Sex: FEMALEMin Age: 35 YearsMax Age: 60 Years
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying a new treatment for people with body composition, estrogen level, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 35 Years to 60 Years.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07422987
Related Trials
Feasibility of Lower-Body EMS Resistance Training in Postmenopausal Women
NCT076287901 location
Effects of Blood Flow Restriction Training on Body Composition and Maximal Strength in Military Personnel
NCT076284781 location
Impact of GLP-1 Receptor Agonists on Dry Eye Disease in Patients With Type 2 Diabetes Mellitus and Obesity
NCT076055721 location
Role of Body Composition in Large for Gestational Age Infants (LGA) With Oral Feeding Difficulty
NCT045990102 locations
Slowly Digestible Carbohydrates for GLP-1 Secretion
NCT075725131 location